Drawing for NEUROLENS

USPTO serial 99405779

NEUROLENS

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
REED, NATASHA DEMETRIA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with NEUROLENS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Won

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United States

Goods and services

ClassDescriptionStatusFirst use
005Blood testing kits comprised of medical diagnostic reagents and assays that test and track biomarkers of neurodegenerative diseases and neuron cell deaths; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood to detect and monitor neurodegenerative diseases and patient therapeutic responses; Reagents for use in cfDNA methylation sequencing for medical purposes; Diagnostic test reagents for medical purposesACTIVE—
042Blood testing and analysis services for scientific research purposes; Medical research laboratory services; Providing scientific research information on the detection, diagnosis, monitoring, and evaluation of neurological diseases, treatments, and patient therapeutic responsesACTIVE—
044Blood testing and analysis services for medical and clinical purposes; Medical laboratory testing and analysis services for the diagnosis and treatment of persons; Providing medical and health information on the detection, diagnosis, monitoring, and evaluation of neurological diseases, treatments, and patient therapeutic responsesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
May 5, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 17, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 17, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 17, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 17, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 22, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance